Guinea-Bissau vs Mozambique: Treatment coverage for schistosomiasis
Guinea-Bissau
8.5%
in 2024
Mozambique
1.0%
in 2023
Guinea-Bissau rank
42nd
Mozambique rank
44th
Treatment coverage for schistosomiasis over time
- Guinea-Bissau
- Mozambique
How they compare
Guinea-Bissau currently reports 8.5% against 1.0% in Mozambique, a difference of 7.5%.
That makes Guinea-Bissau's figure about 8.3 times Mozambique's.
Guinea-Bissau ranks 42nd and Mozambique ranks 44th of 45 countries.
Guinea-Bissau has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 58.2% | 29.5% | 28.6% | Guinea-Bissau |
| 2020s | 44.8% | 30.5% | 14.4% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Guinea-Bissau or Mozambique?
- Guinea-Bissau, at 8.5% against 1.0% in Mozambique as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Guinea-Bissau and Mozambique?
- 7.5%, with Guinea-Bissau ahead.
- How do Guinea-Bissau and Mozambique rank globally for treatment coverage for schistosomiasis?
- Guinea-Bissau ranks 42nd and Mozambique ranks 44th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.